BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30373873)

  • 1. Morphoproteomics and Biomedical Analytics Identify the c-Myc, EZH2, Sirt1 and CXCR4 Pathways as Potential Blocks to Differentiation Leading to Proliferation and Metastatic Potential in Sinonasal Undifferentiated Carcinoma (SNUC) and Provide Therapeutic Options: A Case Study.
    Brown RE; Roy S; McGuire MF
    Ann Clin Lab Sci; 2018 Sep; 48(5):659-664. PubMed ID: 30373873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphoproteomics Identifies SIRT1, EZH2 and CXCR4 Pathways in Diffuse Large B-Cell Lymphoma: Therapeutic Implications.
    Brown RE; Zhang S; Wang XI
    Ann Clin Lab Sci; 2022 Jan; 52(1):27-32. PubMed ID: 35181615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.
    Brown RE; Naqvi S; McGuire MF; Buryanek J; Karni RJ
    J Otolaryngol Head Neck Surg; 2017 Aug; 46(1):52. PubMed ID: 28818106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphoproteomics Identifies the EZH2 and SIRT1 Pathways as Potential Blocks to Differentiation in Yolk Sac Tumor of the Ovary and Provides Therapeutic Options: a Case Study.
    Kojima YA; Assylbekova B; Zhao B; Nugent E; Brown RE
    Ann Clin Lab Sci; 2017 Jan; 47(1):88-91. PubMed ID: 28249923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinonasal undifferentiated carcinoma (SNUC): morphoproteomic-guided treatment paradigm with clinical efficacy.
    Ansari M; Guo S; Fakhri S; Citardi MJ; Blanco A; Patino M; Buryanek J; Amato R; Karni R; Brown RE
    Ann Clin Lab Sci; 2013; 43(1):45-53. PubMed ID: 23462605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphoproteomics Identifies SIRT1 and EZH2 Pathways as Commonalities in B-cell Acute Lymphoblastic Leukemia: Pathogenetic Implications and Opportunities for Therapeutic Intervention.
    Brown RE; Konopka KE; Weerasinghe P; Jaitly V; Dasgupta A; McGuire MF; Nguyen ND
    Ann Clin Lab Sci; 2017 Jan; 47(1):3-9. PubMed ID: 28249909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUT Midline Carcinoma: Morphoproteomic Characterization with Genomic and Therapeutic Correlates.
    Sun H; McGuire MF; Zhang S; Brown RE
    Ann Clin Lab Sci; 2015; 45(6):692-701. PubMed ID: 26663801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: pathogenesis and therapeutic options.
    Brown RE; Buryanek J; Tammisetti VS; McGuire MF; Csencsits-Smith K
    Oncotarget; 2016 Jul; 7(27):41612-41621. PubMed ID: 27223432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenesis recapitulates embryogenesis via the hypoxia pathway: morphoproteomics and biomedical analytics provide proof of concept and therapeutic options.
    Brown RE; McGuire MF
    Ann Clin Lab Sci; 2012; 42(3):243-57. PubMed ID: 22964612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinonasal undifferentiated carcinoma metastatic to the skin.
    Sohsman M; Yang HM; Cassarino DS
    J Cutan Pathol; 2010 Dec; 37(12):1241-4. PubMed ID: 19682175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV).
    Wadsworth B; Bumpous JM; Martin AW; Nowacki MR; Jenson AB; Farghaly H
    Head Neck Pathol; 2011 Dec; 5(4):349-54. PubMed ID: 21805120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
    van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
    Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
    Ejaz A; Wenig BM
    Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphoproteomics Identifies CXCR4 in Undifferentiated Colorectal Cancer: A Case Study with Therapeutic Implications.
    Brown RE; Ali YD; Cai Z
    Ann Clin Lab Sci; 2020 Mar; 50(2):266-269. PubMed ID: 32366567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic management of sinonasal undifferentiated carcinoma.
    Tyler MA; Holmes B; Patel ZM
    Curr Opin Otolaryngol Head Neck Surg; 2019 Feb; 27(1):59-66. PubMed ID: 30507692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
    Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
    Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.
    Heft Neal ME; Birkeland AC; Bhangale AD; Zhai J; Kulkarni A; Foltin SK; Jewell BM; Ludwig ML; Pinatti L; Jiang H; McHugh JB; Marentette L; McKean EL; Brenner JC
    BMC Cancer; 2021 May; 21(1):636. PubMed ID: 34051734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinonasal undifferentiated carcinoma with orbital invasion: report of three cases.
    Sharara N; Muller S; Olson J; Grist WJ; Grossniklaus HE
    Ophthalmic Plast Reconstr Surg; 2001 Jul; 17(4):288-92. PubMed ID: 11476180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study.
    Brown RE; Buryanek J; McGuire MF
    Ann Clin Lab Sci; 2017 Aug; 47(4):457-465. PubMed ID: 28801373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis.
    Ahn PH; Mitra N; Alonso-Basanta M; Adappa ND; Palmer JN; O'Malley BW; Rassekh CH; Chalian A; Cohen RB; Lin A
    Br J Radiol; 2016; 89(1058):20150488. PubMed ID: 26559439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.